A touch of MS: Therapeutic mislabeling

Neurology

Volumn 78, Issue 24, 2012, Pages 1981-1985

  Boissy, Adrienne R ^a   Ford, Paul J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ERROR; HUMAN; MEDICAL ETHICS; MULTIPLE SCLEROSIS; NEUROLOGIST; PATIENT CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RISK ASSESSMENT; THERAPEUTIC MISLABELING;

EID: 84863593445     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318259e0ec     Document Type: Article

References (21)

1. Hankey GJ, Stewart-Wynne EG. Pseudo-multiple sclerosis: a clinico-epidemiological study. Clin Exp Neurol 1987;24:11-19.
2. Kanaan RA, Armstrong D, Wessely SC. Neurologists' understanding and management of conversion disorder. J Neurol Neurosurg Psychiatry 2011;82:961-966.
3. Fink P, Hansen MS, Sondergaard L, Frydenberg M. Mental illness in new neurological patients. J Neurol Neurosurg Psychiatry 2003;74:817-819.
4. Lempert T, Dieterich M, Huppert D, Brandt T. Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurol Scand 1990;82:335-340.
5. Carson AJ, Ringbauer B, Stone J, McKenzie L, Warlow C, Sharpe M. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 2000; 68:207-210.
6. Mace CJ, Trimble MR. 'Hysteria,' 'functional' or 'psychogenic'? A survey of british neurologists' preferences. J R Soc Med 1991;84:471-475.
7. Sigurdardottir KR, Olafsson E. Incidence of psychogenic seizures in adults: a population-based study in Iceland. Epilepsia 1998;39:749-752.
8. Howell SJ, Owen L, Chadwick DW. Pseudostatus epilepticus. Q J Med 1989;71:507-519.
9. Allet JL, Allet RE. Somatoform disorders in neurological practice. Curr Opin Psychiatry 2006;19:413-420.
10. Kranick S, Ekanayake V, Martinez V, Ameli R, Hallett M, Voon V. Psychopathology and psychogenic movement disorders. Mov Disord 2011;26:1844-1850.
11. Stone J, Carson A, Sharpe M. Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry 2005;76(suppl 1):i2-i12.
12. McDonald WI, Compston DA, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol 2005;58:840-846.
14. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the Mc-Donald criteria. Ann Neurol 2011;69:292-302.
15. Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005;76(suppl 1):i13-i21.
16. Reuber M, Mitchell AJ, Howlett SJ, Crimlisk HL, Grunewald RA. Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry 2005; 76:307-314.
17. Benbadis SR. The problem of psychogenic symptoms: Is the psychiatric community in denial? Epilepsy Behav 2005;6:9-14.
18. Lacey C, Cook M, Salzberg M. The neurologist, psychogenic nonepileptic seizures, and borderline personality disorder. Epilepsy Behav 2007;11:492-498.
19. Stein T, Frankel RM, Krupat E. Enhancing clinician communication skills in a large healthcare organization: a longitudinal case study. Patient Educ Couns 2005;58:4-12.
20. Kanner AM. Is the neurologist's role over once the diagnosis of psychogenic nonepileptic seizures is made? No! Epilepsy Behav 2008;12:1-2.
21. Stone J, Carson A, Sharpe M. Wall between neurology and psychiatry: some parts of the wall are thicker than others. BMJ 2002;325:778.